These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21785961)

  • 1. Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature.
    Edrees A
    Rheumatol Int; 2012 Jan; 32(1):1-3. PubMed ID: 21785961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection.
    Schafranski MD
    Rheumatol Int; 2010 Mar; 30(5):679-80. PubMed ID: 19466419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis.
    Meador R; Hsia E; Kitumnuaypong T; Schumacher HR
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S130-4. PubMed ID: 12463463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.
    Almoallim H; Jali I; Wali G
    Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation of ankylosing spondylitis after chlamydial infection in a patient well-controlled with etanercept.
    Kim GT
    Int J Rheum Dis; 2012 Oct; 15(5):e113-5. PubMed ID: 23083043
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion.
    Gill H; Majithia V
    Clin Rheumatol; 2008 Jan; 27(1):121-3. PubMed ID: 17643185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spondyloarthropathies in 2010: new insights into therapy-TNF blockade and beyond.
    Sieper J
    Nat Rev Rheumatol; 2011 Feb; 7(2):78-80. PubMed ID: 21289612
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
    van Vollenhoven RF; Chatzidionysiou K
    Nat Rev Rheumatol; 2013 Sep; 9(9):510-2. PubMed ID: 23897440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept treatment in Sweet's syndrome with inflammatory arthritis.
    Ambrose NL; Tobin AM; Howard D
    J Rheumatol; 2009 Jun; 36(6):1348-9. PubMed ID: 19509095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
    Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD
    Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis: still a chronic disease.
    Miossec P
    Lancet; 2013 Mar; 381(9870):884-6. PubMed ID: 23332235
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience.
    Richard-Miceli C; Dougados M
    BioDrugs; 2001; 15(4):251-9. PubMed ID: 11437690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE; Worsley A; Smith JM; Thomas SH
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial.
    Flagg SD; Meador R; Hsia E; Kitumnuaypong T; Schumacher HR
    Arthritis Rheum; 2005 Aug; 53(4):613-7. PubMed ID: 16082643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-α blockade with etanercept.
    Cavagna L; Sepe V; Bobbio-Pallavicini F; Mangione F; Caporali R; Montecucco C
    Int Urol Nephrol; 2011 Sep; 43(3):909-12. PubMed ID: 20559723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis.
    Tikiz H; Arslan O; Pirildar T; Tikiz C; Bayindir P
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):98-103. PubMed ID: 20382605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.
    Seriolo B; Paolino S; Ferrone C; Cutolo M
    Clin Rheumatol; 2007 Oct; 26(10):1799-800. PubMed ID: 17646897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.